Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSuperdry Regulatory News (SDRY)

Share Price Information for Superdry (SDRY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.50
Bid: 3.50
Ask: 4.135
Change: -0.39 (-10.03%)
Spread: 0.635 (18.143%)
Open: 3.89
High: 4.445
Low: 3.50
Prev. Close: 3.89
SDRY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

30 Jul 2018 15:45

RNS Number : 2075W
Superdry PLC
30 July 2018
 

SuperdryPlc

 

("Superdry") ("the Company")

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them ("PCA")

Superdry Performance Share Plan ("PSP"): Grant of 2018 Conditional Share Awards

 

On 25 July 2018, the PDMRs named below were granted conditional share awards over Ordinary Shares under the terms of the Superdry 2018 Performance Share Plan ("PSP"). Details of the number of Ordinary Shares subject to such awards are set out in the table immediately below.

 

Name / Position of PDMR

Number of Ordinary Shares subject to award

 

Ed Barker - Chief Financial Officer

42,217

Simon Callander - Group General Counsel and Company Secretary

17,990

Andrea Cartwright - Group HR Director

15,929

Paula Kerrigan - Group Strategy and Transformation Director

21,082

Chris Lacey - Digital Director

15,310

Euan Sutherland - Chief Executive Officer

109,318

Nick Tatum - Global Retail Director

21,082

Thomas Vulliez - Vice President USA

20,729

Jon Wragg - Global Trading Director

22,966

 

The above awards were notified to the Company by each PDMR referred to above on 27 July 2018.

 

No consideration was paid for the grant of these awards which are structured as conditional awards.

 

The vesting of an award is subject to the satisfaction of the following performance conditions, measured over a performance period of three financial years of the Company ending with the 2020/2021 financial year (the "performance period"):

1. 70% of the award is based on the compound annual growth rate ("CAGR") in the Company's earnings per share ("EPS") measured over the performance period.

· 25% of the EPS-related part of the award will vest if the CAGR in the EPS is 8%, increasing on a straight-line basis to 50% vesting if the CAGR in the EPS is 10% and increasing on a straight-line basis to 100% vesting if the CAGR in the EPS is 12% or more.

2. 30% of the award is based on comparing the Company's total shareholder return ("TSR") measured over the performance period against the TSR over the performance period of each company in a bespoke group of companies ("Comparator Group").

· 25% of the TSR-related part of the award will vest if the Company's TSR is ranked at the median of the companies in the Comparator Group by reference to their TSR, increasing on a straight-line basis to 100% vesting if the Company's TSR is ranked at the upper quartile or above of the companies in the Comparator Group by reference to their TSR.

Performance against each target is assessed independently. The award will normally vest on the later of the third anniversary of grant and the determination of the performance conditions. The awards are subject to the rules of the PSP and in particular the malus and clawback provisions set out therein.

This announcement, including the notifications below, is made in accordance with the requirements of the EU Market Abuse Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1. Ed Barker

2. Simon Callander

3. Andrea Cartwright

4. Paula Kerrigan

5. Chris Lacey

6. Euan Sutherland

7. Nick Tatum

8. Thomas Vulliez

9. Jon Wragg

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

1. Chief Financial Officer/PDMR

2. Group General Counsel and Company Secretary/PDMR

3. Group HR Director/PDMR

4. Group Strategy and Transformation Director/PDMR

5. Digital Director/PDMR

6. Chief Executive Officer/PDMR

7. Global Retail Director/PDMR

8. Vice President USA/PDMR

9. Global Trading Director/PDMR

 

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Superdry Plc

b)

 

LEI

 

213800GAQMT2WL7BW361

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 5 pence each

 

 

 

ISIN: GB00B60BD277

 

b)

 

Nature of the transaction

 

 

Grant of conditional share awards under the Superdry 2018 Performance Share Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1. £13.324

2. £13.324

3. £13.324

4. £13.324

5. £13.324

6. £13.324

7. £13.324

8. £13.324

9. £13.324

 

1. 42,217

2. 17,990

3. 15,929

4. 21,082

5. 15,310

6. 109,318

7. 21,082

8. 20,729

9. 22,966

d)

 

Aggregated information

 

 

Price(s)

 

Aggregated Volume(s)

1. £562,499.31

2. £239,698.76

3. £212,238.00

4. £280,896.57

5. £203,990.44

6. £1,456,553.03

7. £280,896.57

8. £276,193.20

9. £305,998.98

 

1. 42,217

2. 17,990

3. 15,929

4. 21,082

5. 15,310

6. 109,318

7. 21,082

8. 20,729

9. 22,966

e)

 

Date of the transaction

 

25 July 2018

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

30 July 2018

 

For further information:

 

Superdry Plc

Simon Callander

Company Secretary

+44 (0) 1242 586643

simon.callander@superdry.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHWGUWCMUPRGCU
Date   Source Headline
24th Jul 20204:36 pmRNSPrice Monitoring Extension
23rd Jul 20209:34 amRNSHolding(s) in Company
21st Jul 202011:38 amRNSHolding(s) in Company
21st Jul 202011:29 amRNSHolding(s) in Company
20th Jul 20202:12 pmRNSHolding(s) in Company
14th Jul 202010:03 amRNSDirector/PDMR Shareholding
2nd Jul 202010:34 amRNSHolding(s) in Company
2nd Jul 202010:23 amRNSHolding(s) in Company
2nd Jul 20209:47 amRNSHolding(s) in Company
30th Jun 202010:21 amRNSTotal Voting Rights
29th Jun 20209:20 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:36 pmRNSPrice Monitoring Extension
18th Jun 20207:00 amRNSStatement re China Joint Venture
16th Jun 20209:14 amRNSDirector/PDMR Shareholding
2nd Jun 202011:29 amRNSHolding(s) in Company
29th May 202012:02 pmRNSPrice Monitoring Extension
29th May 20209:28 amRNSTotal Voting Rights
26th May 202012:02 pmRNSPrice Monitoring Extension
22nd May 20204:15 pmRNSHolding(s) in Company
15th May 20204:41 pmRNSSecond Price Monitoring Extn
15th May 20204:36 pmRNSPrice Monitoring Extension
14th May 20209:48 amRNSDirector/PDMR Shareholding
12th May 202012:02 pmRNSPrice Monitoring Extension
7th May 20207:00 amRNSTrading Statement
30th Apr 20202:00 pmRNSTotal Voting Rights
22nd Apr 202012:07 pmRNSSecond Price Monitoring Extn
22nd Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 20202:15 pmRNSDirector/PDMR Shareholding
9th Apr 20209:00 amRNSDirector Declaration
3rd Apr 20209:04 amRNSHolding(s) in Company
31st Mar 202011:28 amRNSTotal Voting Rights
31st Mar 202010:46 amRNSHolding(s) in Company
27th Mar 20204:37 pmRNSPrice Monitoring Extension
26th Mar 202012:02 pmRNSPrice Monitoring Extension
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:37 pmRNSPrice Monitoring Extension
24th Mar 202010:15 amRNSHolding(s) in Company
23rd Mar 20202:34 pmRNSBlock listing Interim Review
18th Mar 20207:00 amRNSStatement re Current trading and COVID-19 update
16th Mar 202010:42 amRNSDirector/PDMR Shareholding
4th Mar 20209:21 amRNSHolding(s) in Company
2nd Mar 20204:17 pmRNSHolding(s) in Company
28th Feb 20208:54 amRNSTotal Voting Rights
14th Feb 202011:58 amRNSDirector/PDMR Shareholding
31st Jan 20203:42 pmRNSTotal Voting Rights
28th Jan 20202:25 pmRNSDirector Declaration
28th Jan 20209:18 amRNSDirector/PDMR Shareholding
20th Jan 20203:35 pmRNSDirector/PDMR Shareholding
14th Jan 20209:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.